BARTLETT GROUP PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: H81013 | CAMBERLEY, GU16 6QQ
Showing results 551-600 of 806
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Pilocarpine hydrochloride | 37 | 1,708 | £798 | +244.3% ▲ |
| 37 | 215 | £600 | +410.7% ▲ | |
| Glyceryl trinitrate | 36 | 1,110 | £1.4K | +171.0% ▲ |
| Ipratropium bromide | 36 | 153 | £206 | +25.2% ▲ |
| Cabergoline | 36 | 368 | £637 | +132.2% ▲ |
| Hydroxycarbamide | 36 | 2,026 | £319 | +24.8% ▲ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 36 | 100.2K | £2.2K | +352.1% ▲ |
| Emulsifying wax | 36 | 31.0K | £220 | +195.5% ▲ |
| 36 | 1,220 | £3.2K | +648.5% ▲ | |
| Levonorgestrel | 35 | 1,883 | £50 | +330.5% ▲ |
| Pyridostigmine bromide | 35 | 7,200 | £932 | +104.5% ▲ |
| Adapalene | 35 | 1,665 | £577 | +59.9% ▲ |
| 35 | 5,395 | £126 | +39.2% ▲ | |
| 35 | 51 | £5.3K | +301.9% ▲ | |
| Rufinamide | 34 | 26.2K | £5.1K | +98.1% ▲ |
| Vardenafil | 34 | 136 | £265 | +143.5% ▲ |
| 34 | 1,710 | £80 | -37.4% ▼ | |
| Propantheline bromide | 33 | 2,912 | £2.5K | +154.2% ▲ |
| Sodium picosulfate | 33 | 9,500 | £879 | -9.1% ▼ |
| Lofepramine hydrochloride | 33 | 1,624 | £697 | +10.3% ▲ |
| Rifaximin | 33 | 1,848 | £8.6K | +22.9% ▲ |
| Prasterone | 33 | 924 | £500 | +400.0% ▲ |
| Sodium fluoride | 33 | 2,128 | £184 | -0.5% vs avg |
| Ergocalciferol | 33 | 1,319 | £983 | +97.1% ▲ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 33 | 416 | £778 | +232.3% ▲ |
| Ready to serve infant formula, high energy (0913104) | 33 | 428.7K | £6.4K | +198.7% ▲ |
| 33 | 641 | £531 | +58.4% ▲ | |
| Glycopyrronium bromide | 32 | 960 | £826 | -14.1% ▼ |
| Midazolam hydrochloride | 32 | 104 | £2.3K | +122.0% ▲ |
| Propylthiouracil | 32 | 2,800 | £352 | +154.6% ▲ |
| Drospirenone | 32 | 2,688 | £447 | +397.2% ▲ |
| Acetic acid | 32 | 175 | £164 | +176.3% ▲ |
| 32 | 747 | £1.4K | +80.4% ▲ | |
| 32 | 4,100 | £455 | -33.6% ▼ | |
| Propafenone hydrochloride | 31 | 2,576 | £241 | +186.3% ▲ |
| Mebendazole | 31 | 460 | £40 | +170.8% ▲ |
| Glimepiride | 31 | 1,064 | £33 | -66.4% ▼ |
| Liraglutide | 31 | 94 | £3.7K | +479.1% ▲ |
| Methocarbamol | 31 | 3,298 | £216 | -35.2% ▼ |
| Menthol | 31 | 12.7K | £460 | +10.1% ▲ |
| Aciclovir | 31 | 192 | £180 | +151.4% ▲ |
| 31 | 32 | £363 | +210.0% ▲ | |
| 31 | 1,640 | £5.7K | +27.3% ▲ | |
| 31 | 1,010 | £5.9K | +169.4% ▲ | |
| Prasugrel | 30 | 840 | £117 | -4.5% ▼ |
| Simple | 30 | 6,000 | £43 | +161.3% ▲ |
| Amisulpride | 30 | 1,338 | £632 | -57.3% ▼ |
| Phased formulations of ethinylestradiol | 30 | 1,995 | £113 | +572.2% ▲ |
| Etodolac | 30 | 900 | £442 | +8.4% ▲ |
| Azelastine hydrochloride | 30 | 264 | £201 | +152.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.